Related Experiment Video
Updated: Jul 2, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
First episode and recurrent venous thromboembolism: who is identifiably at risk?
Timothy K Liem1, Thomas G Deloughery
1Division of Vascular Surgery, Oregon Health and Science University, OP-11, 3181 SW Sam Jackson Park Road, Portland, OR, USA. liemt@ohsu.edu
Abstract:
Management of venous thromboembolism (VTE) has undergone a significant evolution in the past two decades. Two of the more common heritable thrombophilias were identified (Factor V Leiden and prothrombin 20210A gene mutation) in the early to mid-1990s. These and other inherited and acquired hypercoagulable conditions were found to place patients at higher risk for developing a first episode of VTE. However, their roles in development of recurrent VTE remain uncertain. More recently, other clinical risk factors that are associated with increased risk for VTE have been identified. This information has allowed physicians to stratify the type and duration of anticoagulation based not only on the presence of thrombophilias, but also on other clinical characteristics that increase risk for a first episode of and recurrent VTE.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Venous Thrombosis IV: Nursing Management